Strainprint Featured in The GrowthOp – Four in 10 respondents with medical conditions opting for cannabis to reduce pharmaceutical use: Strainprint Report notes that cost and lack of insurance coverage remain two key hurdles to clear By Tamara Lilien August 5, 2019 What role might medical cannabis play in mitigating polypharmacy, or using more than one […]
Recent concerns demonstrate need to build on the positive foundation that exists.